Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer: a Population Study of the US Database and a Chinese Multi-institutional Registry

NCT05572151 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT05572151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05572151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer: a Population Study of the US Database and a Chinese Multi-institutional Registry
Lead sponsor
The Second Affiliated Hospital of Harbin Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2009
Completion date
December 31, 2018
Enrollment
7,694 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer